The interaction of parathyroid hormone and aluminum in renal osteodystrophy (Q57227435)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

The interaction of parathyroid hormone and aluminum in renal osteodystrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

0 references

1 reference

E Slatopolsky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

language of work or name

English

0 references

publication date

1 March 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

842-854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

29 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Bone and soft tissue changes with oral phosphate supplements

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Intestinal absorption of calcium and the effect of renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

The Acute Effects of 1,25-Dihydroxycholecalciferol on Serum Immunoreactive Parathyroid Hormone in the Dog*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Gastrointestinal absorption of aluminum from aluminum-containing antacids

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Hyperaluminaemia from aluminum resins in renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Aluminum transfer during hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and "epidemic" forms of the syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Aluminum associated bone disease: clinico-pathologic correlation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Suppression of parathyroid hormone secretion by aluminum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Aluminum Uptake by the Parathyroid Glands

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Effects of aluminum on bovine parathyroid adenylate cyclase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

In vitro model of aluminum-induced osteomalacia: Inhibition of hydroxyapatite formation and growth

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Bone aluminum and histomorphometric features of renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Osteomalacia after parathyroidectomy in patients with uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Do Parathyroid Hormone and 1,25-Dihydroxyvitamin D Modulate Bone Formation In UremiaÓ*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

The milk alkali syndrome: a study of the acute disorder with comments on the development of the chronic condition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

The milk-alkali syndrome: current concepts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Aluminum-induced anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Oral aluminum administration to uremic, hyperparathyroid, or vitamin D-supplemented rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.75

7 January 2021

Identifiers

DOI

10.1038/KI.1987.75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3573543%20AND%20SRC:MED&resulttype=core&format=json